March 27, 2026 MASLD Subtypes Identified: New Algorithm for Personalized Risk Assessment & Management
March 19, 2026 Inflammation Linked to Immunotherapy Resistance in Bladder Cancer: New Study Reveals Pathway
March 4, 2026 Mount Sinai & KSU Medical City Collaborate on IBD Research in Saudi Families OR IBD: New Study to Focus on Genetic Risk & Personalized Treatment OR Saudi-US Partnership to Advance IBD Biomarker Discovery & Early Diagnosis
